Global Huntington’s Disease Market Projected to Expand at 17.7% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Huntington’s Disease Market Expected To Become By 2029 Compared With Its 2025 Level?

The Huntington’s disease market size has seen rapid expansion in recent years. It is anticipated to increase from $0.47 billion in 2024 to $0.55 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.0%. The historical growth of this market can be attributed to several factors, including increasing public understanding of chronic diseases, a rise in government awareness initiatives, growing government efforts to spread information about Huntington’s disease, an expanding geriatric demographic, and increased research into genetic disorders.

The huntington’s disease market is projected to experience swift expansion over the coming years. This market is anticipated to reach $1.05 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.7%. The expansion anticipated during this period stems from the increasing incidence of neurological conditions, heightened public consciousness, escalating healthcare spending, increased investments in research and development, and a rise in clinical research initiatives. Key developments expected in the forecast timeframe encompass the integration of novel medications, extensive drug innovation, the emergence of new technologies, continuous technological improvements, and a strong demand for advanced solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22008&type=smp

What Are The Top Growth Drivers Impacting The Huntington’s Disease Market Outlook?

The increasing occurrence of neurological disorders is projected to boost the expansion of the huntington’s disease market in the future. These neurological conditions are medical ailments that impact the brain, spinal cord, and nerves, leading to symptoms such as impaired movement, coordination, sensation, or cognitive function. The rise in neurological disorders can be linked to factors like aging populations, environmental toxins, changes in lifestyle, improved diagnostic capabilities, and genetic predispositions, which facilitate the detection and identification of more cases. Huntington’s disease is a neurodegenerative condition stemming from a genetic mutation, manifesting as motor dysfunction, cognitive decline, and psychiatric symptoms that progressively worsen over time. For example, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, stated that an estimated 6.7 million Americans aged 65 and older currently live with Alzheimer’s dementia. Without significant medical advancements to prevent, slow, or cure this disease, this figure could escalate to 13.8 million by 2060. Therefore, the growing prevalence of neurological disorders is stimulating the growth of the huntington’s disease market.

Which Key Segments Fueling The Huntington’s Disease Market?

The huntington’s diseasemarket covered in this report is segmented –

1) By Treatment Type: Symptomatic Therapy; Disease-Modifying Therapy; Other Treatment Types

2) By Diagnosis: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Genetic Testing; Other Diagnosis

3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Symptomatic Therapy: Antipsychotics; Antidepressants; Mood Stabilizers; Muscle Relaxants

2) By Disease-Modifying Therapy: Gene Silencing Therapies; Stem Cell Therapy; Neuroprotective Agents

3) By Other Treatment Types: Physical Therapy; Occupational Therapy; Speech Therapy

How Are Trends Influencing The Huntington’s Disease Market?

Major companies within the huntington’s disease market are focusing their efforts on creating innovative solutions, such as oral small molecule drugs, aimed at managing symptoms and slowing the disease’s advancement. An oral small molecule drug is a low-molecular-weight compound that can be consumed orally and is engineered to engage with biological targets, including proteins or enzymes, to treat various conditions. For instance, in September 2024, PTC Therapeutics Inc., a US-based pharmaceutical company, obtained Fast Track designation from the U.S. Food and Drug Administration (USFDA) for its PTC518 program, which is designed for treating Huntington’s disease. This designation is granted to therapies that address significant unmet medical needs, highlighting the potential of PTC518 as a disease-modifying treatment for individuals affected by this genetic disorder.

Which Leading Companies Dominate The Huntington’s Disease Market Share?

Major companies operating in the huntington’s disease market are Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Ipsen S.A., Vertex Pharmaceuticals Incorporated, H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc, PTC Therapeutics Inc., Annexon Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Vaccinex Inc., SOM Biotech S.L., Alterity Therapeutics Limited, Medesis pharma SA.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/huntingtons-disease-global-market-report

Which Geographies Are Emerging As Strong Markets For The Huntington’s Disease Industry?

North America was the largest region in the huntington’s disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington’s disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Huntington’s Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22008&type=smp

Browse Through More Reports Similar to the Global Huntington’s Disease Market 2025, By The Business Research Company

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Brain Tumor Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795